Company profile: Neurescence
1.1 - Company Overview
Company description
- Provider of biological optical imaging solutions for neuroscience, offering miniature fluorescence microscopes and systems for dual-color, multi-region, and cellular-resolution calcium imaging in freely behaving animals, with synchronized behavioral data and optogenetic manipulation, plus software and a cloud platform to manage, analyze, and share multimodal research data.
Products and services
- Quartet System: A miniature fluorescence multi-region imaging system that performs calcium imaging and behavioral assessment in freely-behaving animals, with software to save microscope photos and extract activity per selected neuron
- IDEAS Platform: A cloud-based platform that manages, analyzes, and shares multimodal neuroscience research data using prebuilt workflows and powerful cloud computing
- NVoke System: A system integrating in vivo cellular-resolution calcium imaging with optogenetic manipulation to interrogate neural circuit dynamics and behavior
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Neurescence
Teneobio
HQ: United States
Website
- Description: Provider of human heavy chain antibody discovery and development, with pre-clinical and clinical programs for multiple myeloma, prostate cancer, and immune disorders. Its antibody discovery engine is based on UniRat™.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Teneobio company profile →
BioServ
HQ: United Kingdom
Website
- Description: Provider of biotechnology services specializing in upstream production and downstream processing of antibodies and other proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioServ company profile →
Oasmia
HQ: Sweden
Website
- Description: Provider of human and veterinary oncology drugs, developing, manufacturing, marketing and selling novel formulations of well-established cytostatics with improved properties, reduced side effects and expanded therapeutic use. Portfolio includes Paccal Vet (XR-17) for canine cancers, Cantrixil for blood cancer, Docetaxel micellar for prostate cancer, and XR-18 delivery technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oasmia company profile →
Axion Biosystems
HQ: United States
Website
- Description: Provider of multi-electrode array and impedance-based platforms for real-time, continuous, label-free cellular analysis, including monitoring of proliferation, viability, morphology, attachment, signaling, and immune cell-mediated killing. Offers single- and multi-well systems, high-throughput formats, automation modules, and integrated circuits to eliminate stimulation artifacts for research, clinical, and drug discovery markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axion Biosystems company profile →
BioSeek
HQ: United States
Website
- Description: Provider of cell-based human disease models for drug discovery and development, offering BioMap Systems—human primary cell-based assay systems for indications in vascular inflammation, cardiovascular and respiratory diseases, and fibrosis—and programs for the discovery of lead compounds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioSeek company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Neurescence
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Neurescence
2.2 - Growth funds investing in similar companies to Neurescence
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Neurescence
4.2 - Public trading comparable groups for Neurescence
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →